Product Name:

NebuPeptide™ Carfilzomib (Peptide Reference)

Catalog Number:

NBS-233763

Description:

NebuPeptide™ Carfilzomib (Peptide Reference)(CAT#NBS-233763) is synthesized in accordance with the Carfilzomib sequence and can be utilized for a variety of in vivo and in vitro studies, including quality control, bioactivity verification, immunization, drug development, structural analysis, etc. Nebula Biotechnology Co., Ltd. is capable of providing Insulin Human reference peptide ranging from milligrams to kilograms.

Peptide Name:

Carfilzomib (卡非佐米)

Background:

Carfilzomib (PR-171) is an irreversible proteasome inhibitor with an IC50 of<5 nM. It preferentially inhibits ChT-L activity of the β 5 subunit in vitro and has weak or no effect on PGPH and T-L activity.

Alias:

PR-171; PR 171; PR171; Carflizomib; Kyprolis

CAS Number:

868540-17-4

Formula:

C40H57N5O7

Molecular Weight:

719.91

Purity:

see COA

Solubility:

see COA

Storage & Shipment:

Store at -20℃; ship with blue ice.

For R&D use only!

To get more information, please contact us freely.